Podcasts about endobronchial

Lung surgery, like every other type of surgery, can have complications that sometimes require further procedures to be dealt with. Surgeons are always looking for new ways to keep these procedures as minimally invasive as possible, but they also have to ensure these are effective and safe. Consultant surgeon Mr David Waller  and his surgical trainee Miss Michelle Lee at the Department of Thoracic Surgery in St Bartholomew's Hospital, London, routinely deal with complex cases of lung surgery. They have recently shared an unusual case of foreign body migration of an endobronchial valve implanted  in one of  their patients.Read some of their latest work here:  https://doi.org/10.1177/20542704221074148

CHEST January 2023, Volume 163, Issue 1 Kazuhiro Yasufuku, MD, joins CHEST Podcast Moderator, Dominique Pepper MD, to discuss whether a biomarker-based approach to EBUS-TBNA sample assessment could provide a simple alternative to ROSE. DOI: https://doi.org/10.1016/j.chest.2022.07.003

Host: Frank C. Sciurba, MD, FCCP Guest: Emily L. Yee, MD What do we need to know about using endobronchial valves in patients with severe COPD and emphysema? Drs. Frank Sciurba and Emily Yee explore the impact of these valves on patients. This educational podcast is produced in partnership with the American College of CHEST Physicians and sponsored by Pulmonx Corporation, the manufacturer of Zephyr. Click here to find additional educational resources for clinicians and patients.

CHEST September 2022, Volume 162, Issue 3 Nicholas P.J. Romatowski, MD, joins CHEST Podcast Moderator, Dominique Pepper MD, to discuss whether a 19-gauge needle offers greater diagnostic yield and sensitivity vs the 21G and 22G EBUS needles for a diagnosis of sarcoidosis, lymphoma, or mediastinal lymphadenopathy not yet diagnosed? DOI: https://doi.org/10.1016/j.chest.2022.03.041

For certain severe COPD patients who are not responding to bronchodilators and rehabilitation, a new minimally invasive procedure is available that can yield a 15-20% improvement in lung function. As Surya Bhatt, MD, explains, the Zephyr endobronchial valve addresses emphysema via lung volume reduction; the one-way valve is placed through a bronchoscope, without even a stitch. The procedure, performed under conscious sedation or general anesthesia, can dramatically improve patients' quality of life if they meet certain criteria. Learn more from Dr. Bhatt about the importance of intact fissures, the ideal differences in respective lung lobe performance, and the critical tests he uses to determine if this procedure is right for your patient.

Kevin MA MD discusses endobronchial valve placement for emphysema/COPD. He shares this breakthrough treatment and how the specialists at Penn medicine help patients to breathe more easily without major surgery.

This podcast was recorded by The American Association for Bronchology and Interventional Pulmonology.

Patients are delaying their health needs due to COVID-19. Dr. Jamie Rutland, Board-Certified Pulmonary and Critical Care Physician, discusses "My Health Can't Wait" an educational effort and resource hub launched by Johnson & Johnson Medical Devices Companies that provide patients and healthcare providers with tools to help them engage in meaningful conversations about prioritizing needed care, and offers tools such as patient outreach templates, surgery discussion checklists, and telehealth resources. Dr. Cedric “Jamie” Rutland, a Board Certified (Internal Medicine, Pulmonary, Critical Care) Pulmonary and Critical Care Physician based in Southern California, received his medical degree and completed his residency in Internal Medicine from the University of Iowa Carver College of Medicine in Iowa City, IA. Dr. J. Rutland continued his education at the University of Kansas Medical Center specializing in Pulmonary and Critical Care medicine. Dr. J. Rutland practices with Pacific Pulmonary Medical Group and services the Inland Empire and Orange County. His main clinical expertise is focused on the evaluation of difficult cases in Interstitial Lung Disease and COPD. Dr. Rutland is specially trained in Endobronchial ultrasound “EBUS” in addition to bronchoscopy. As an Assistant Clinical Professor at the University of California Riverside, Dr. Rutland teaches and mentors residents rotating at Riverside Community Hospital and at PPMG’s outpatient clinic. In addition to Dr. Rutland’s role at PPMG, he speaks for Device and Pharmaceutical Companies teaching both patients and their families and Doctors, nurses, and others within the medical community. Dr. Rutland is also the face of Medicine Deconstructed, a Youtube channel laying out a variety of medical topics for the laymen and medical professionals. His motivation for this channel and for becoming a Lung Doc stems from his Grandfather’s death during his first year of med school. He will tell you each day he moves down the hospital hallways chasing down a bedside he knows he’ll never catch but is also so grateful for the ones he does. Dr. Rutland is a member of the American College of Chest Physicians and is a diplomate of the American Board of Internal Medicine & Pulmonary Medicine.

Dr. Xuanha “Mimi” White, a board-certified Internal Medicine, Pulmonary, Critical Care, and Sleep Medicine physician with Temecula Valley Hospital, discusses the Endobronchial Ultrasound (EBUS) Bronchoscopy Procedure.

Dr. Gustavo Cumbo-Nacheli, board-certified interventional pulmonologist talks about the Zephyr® Endobronchial Valve, a small umbrella-like object placed in the airway with a camera scope. This new device is made by Pulmonx, was approved by the FDA in 2018 and is helping patients with COPD and Emphysema live better, healthier lives.

Endobronchial valve (Zephyr Valve) placement for advanced emphysema was approved by the FDA in the summer of 2018 and is the first bronchoscopic lung volume reduction procedure approved in the US. Mark Dransfield, MD shares how the Zephyr Valve procedure has been demonstrated to reduce lung volume leading to substantial improvements in lung function, symptoms, and quality of life.

Drs. Gerard Criner and Gaetan Deslee join Nitin Seam to discuss the results of the multi-center LIBERATE trial, the first endobronchial valve study to follow patients for 12 months.

Nitin Seam discusses the results of the IMPACT trial with study author Ralf Eberhardt and author of a related editorial, Nick Hopkinson.

Editor's Audio Summary by Phil B. Fontanarosa, MD, Executive Editor of JAMA, the Journal of the American Medical Association, for the May 24, 2016 issue

Dr. Jed Gorden, Swedish Cancer Institute, describes the differences between bronchoscopy and endobronchial ultrasound, highlighting the advantages of EBUS in diagnosis and staging.

Dr. Jed Gorden, Swedish Cancer Institute, describes the differences between bronchoscopy and endobronchial ultrasound, highlighting the advantages of EBUS in diagnosis and staging.

Dr. Jed Gorden, Swedish Cancer Institute, describes the differences between bronchoscopy and endobronchial ultrasound, highlighting the advantages of EBUS in diagnosis and staging.

Dr. David Harpole of Duke University reviews advances in lung cancer surgery, focusing in this first part on the evolution of techniques to improve staging of lung cancer.

Dr. David Harpole of Duke University reviews advances in lung cancer surgery, focusing in this first part on the evolution of techniques to improve staging of lung cancer.

Purpose: To determine the efficacy of high dose rate endobronchial brachytherapy (HDR-BT) for the treatment of centrally located lung tumors, two different fractionation schedules were compared regarding local tumor response, side effects and survival. Mature retrospective results with longer follow-up and more patients were analyzed. Initial results were published by Huber et al. in 1995. Methods and materials: 142 patients with advanced, centrally located malignant tumors with preferential endoluminal growth were randomized to receive 4 fractions of 3.8 Gy (time interval: 1 week, n = 60, group I) or 2 fractions of 7.2 Gy (time interval: 3 weeks, n = 82, group II) endobronchial HDR-BT. Age, gender, tumor stage, Karnofsky Performance Score and histology were equally distributed between both groups. Results: Local tumor response with 2 fractions of 7.2 Gy was significantly higher as compared to 4 fractions of 3.8 Gy (median 12 vs. 6 weeks; p

This slide presentation by Dr. Gerard Silvestri, pulmonologist at Medical Univ. of South Carolina, covers the key methods of evaluating a new lung cancer, including initial diagnosis and staging studies.

Guest: Andrew Haas, MD, PhD Host: Lee Freedman, MD Until recently, bronchoscopy has involved using cameras with CT guidance to determine abnormalities along the airway and lymph nodes. How is ultrasound now being used for bronchoscopic needle biopsies? What are other novel therapeutic applications for endobronchial ultrasound-guided transbronchial needle aspiration? Dr. Andrew Haas, assistant professor of medicine in the pulmonary, allergy and critical care division at the University of Pennsylvania Medical Center, discusses the diagnostic and therapeutic uses of ultrasound-guided bronchoscopy. Dr. Lee Freedman hosts.

Guest: Andrew Haas, MD, PhD Host: Lee Freedman, MD Until recently, bronchoscopy has involved using cameras with CT guidance to determine abnormalities along the airway and lymph nodes. How is ultrasound now being used for bronchoscopic needle biopsies? What are other novel therapeutic applications for endobronchial ultrasound-guided transbronchial needle aspiration? Dr. Andrew Haas, assistant professor of medicine in the pulmonary, allergy and critical care division at the University of Pennsylvania Medical Center, discusses the diagnostic and therapeutic uses of ultrasound-guided bronchoscopy. Dr. Lee Freedman hosts.